Use of an In Vivo FTA Assay to Assess the Magnitude, Functional Avidity and Epitope Variant Cross-Reactivity of T Cell Responses Following HIV-1 Recombinant Poxvirus Vaccination

• Danushka K. Wijesundara,

  Affiliation Molecular Mucosal Vaccine Immunology Group, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia

  ⨯
• Charani Ranasinghe,

  Affiliation Molecular Mucosal Vaccine Immunology Group, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia

  ⨯
• Ronald J. Jackson,

  Affiliation Molecular Mucosal Vaccine Immunology Group, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia

  ⨯
• Brett A. Lidbury,

  Affiliation Alternatives to Animals through Bioinformatics Group, Dept Genome Biology, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia

  ⨯
• Christopher R. Parish,

  Affiliation Cancer and Vascular Biology Group, Dept Immunology, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia

  ⨯
• Benjamin J. C. Quah

  * E-mail: ben.quah@anu.edu.au

  Affiliation Cancer and Vascular Biology Group, Dept Immunology, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia

  ⨯